title: Tiopronin-induced myasthenia.
authors.forename: A
authors.initials: A
authors.lastname: Cherasse
authors.forename: J F
authors.initials: JF
authors.lastname: Maillefert
authors.forename: J L
authors.initials: JL
authors.lastname: Henlin
authors.forename: D
authors.initials: D
authors.lastname: Chassard
authors.forename: C
authors.initials: C
authors.lastname: Tavernier
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000139:chemically induced*; D009388:Neostigmine / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D008625:Tiopronin / Q000009:adverse effects*
chemical_list: D010277:Parasympathomimetics; D009388:Neostigmine; D008625:Tiopronin; D011729:Pyridostigmine Bromide; D011241:Prednisone